An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action
- 1 March 1997
- journal article
- review article
- Published by Springer Nature in Investigational New Drugs
- Vol. 15 (1) , 49-59
- https://doi.org/10.1023/a:1005770612294
Abstract
Angiogenesis is a biologic process whereby endothelial cells divide and migrate to form new blood vessels. This process is required in physiological conditions, but is also a necessary requirement...Keywords
This publication has 92 references indexed in Scilit:
- Effects of group BStreptococcus toxin on long-term survival of mice bearing transplanted Madison lung tumorsZeitschrift für Krebsforschung und Klinische Onkologie, 1994
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Administration of Pentosan Polysulfate to Patients With Human Immunodeficiency Virus-Associated Kaposi's SarcomaJNCI Journal of the National Cancer Institute, 1993
- The combination of antiagniogenic agents to inhibit primary tumor growth and metastasisJournal of Pediatric Surgery, 1993
- Detectable Inhibition of Heparin-Binding Growth Factor Activity in Sera From Patients Treated With Pentosan PolysulfateJNCI Journal of the National Cancer Institute, 1993
- Antitumor effects of GBS toxin: a polysaccharide exotoxin from group B?-hemolytic streptococcusZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Inhibitory effects of a bacteria‐derived sulfated polysaccharide against basic fibroblast growth factor‐induced endothelial cell growth and chemotaxisJournal of Cellular Physiology, 1993
- Growth Inhibition of Murine Melanoma and Human Colon Carcinoma by Recombinant Human Platelet Factor 4JNCI Journal of the National Cancer Institute, 1990
- Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2aNew England Journal of Medicine, 1989
- Mechanism of action of the new immunomodulator LS2616 on T cell responsesInternational Journal of Immunopharmacology, 1987